A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia
Clinical trial NCT03692052 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03692052
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2020-08-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.